Lu Pan

1.4k total citations
28 papers, 909 citations indexed

About

Lu Pan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Lu Pan has authored 28 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Lu Pan's work include Single-cell and spatial transcriptomics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Lu Pan is often cited by papers focused on Single-cell and spatial transcriptomics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Immunotherapy and Immune Responses (4 papers). Lu Pan collaborates with scholars based in China, Singapore and Sweden. Lu Pan's co-authors include Liyun Lai, Salvatore Albani, Camillus Chua, Brian K. P. Goh, Chun Jye Lim, Pierce K. H. Chow, Valerie Chew, Alexander Chung, Yun Hua Lee and Han Chong Toh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Lu Pan

25 papers receiving 902 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Pan China 13 373 366 242 228 134 28 909
Philipp‐Sebastian Koch Germany 16 271 0.7× 217 0.6× 182 0.8× 348 1.5× 156 1.2× 35 948
Liangrong Shi China 17 544 1.5× 663 1.8× 153 0.6× 255 1.1× 88 0.7× 33 1.2k
Enliang Li China 14 187 0.5× 353 1.0× 84 0.3× 275 1.2× 84 0.6× 52 801
Guomin Jiang China 20 255 0.7× 126 0.3× 121 0.5× 274 1.2× 109 0.8× 42 931
Huiping Gao China 12 392 1.1× 616 1.7× 192 0.8× 248 1.1× 54 0.4× 22 889
Wenwei Zhu China 11 239 0.6× 318 0.9× 175 0.7× 650 2.9× 102 0.8× 19 1.1k
Chahrazade Kantari‐Mimoun France 10 766 2.1× 680 1.9× 89 0.4× 388 1.7× 111 0.8× 11 1.3k
Diego Calabrese Switzerland 18 226 0.6× 466 1.3× 427 1.8× 336 1.5× 322 2.4× 27 1.4k
Haofan Jin China 13 361 1.0× 345 0.9× 49 0.2× 176 0.8× 49 0.4× 25 681
Haoting Sun China 13 364 1.0× 244 0.7× 103 0.4× 713 3.1× 78 0.6× 26 1.2k

Countries citing papers authored by Lu Pan

Since Specialization
Citations

This map shows the geographic impact of Lu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Pan more than expected).

Fields of papers citing papers by Lu Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Pan. The network helps show where Lu Pan may publish in the future.

Co-authorship network of co-authors of Lu Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Pan. A scholar is included among the top collaborators of Lu Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Pan. Lu Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yuxuan, Lu Pan, Qianwen Chen, et al.. (2025). C‐Reactive Protein–Albumin–Lymphocyte (CALLY) Index as an Independent Risk Factor for Postoperative Atrial Fibrillation Recurrence. Clinical Cardiology. 48(6). e70157–e70157.
2.
Luo, Wei, Shengnan Shen, Yuan Zhuang, et al.. (2025). Glaucocalyxin A induces autophagy-mediated ferroptosis by targeting PRDX1 and TXNRD1 proteins in non-small cell lung cancer. Phytomedicine. 148. 157280–157280. 1 indexed citations
3.
Deng, Li, Ye Deng, Lu Pan, et al.. (2025). Explainable Artificial Intelligence–driven Risk Assessment for Malignant Ventricular Arrhythmia and Mortality in Acute Myocardial Infarction. Canadian Journal of Cardiology. 41(12). 2521–2532.
4.
Li, Xuexin, Lu Pan, Weiyuan Li, et al.. (2025). Deciphering immune predictors of immunotherapy response: A multiomics approach at the pan-cancer level. Cell Reports Medicine. 6(4). 101992–101992. 7 indexed citations
6.
Seitz, Christina, Anikó Lovik, Lu Pan, et al.. (2024). Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study. Journal of Neurology. 271(8). 5447–5459. 2 indexed citations
7.
Li, Weiyuan, Lu Pan, Weifeng Hong, et al.. (2024). A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade. Nature Communications. 15(1). 6142–6142. 12 indexed citations
8.
Pan, Lu, Paolo Parini, Roman Tremmel, et al.. (2024). Single Cell Atlas: a single-cell multi-omics human cell encyclopedia. Genome biology. 25(1). 104–104. 18 indexed citations
9.
Pan, Lu, et al.. (2023). Ursa: A Comprehensive Multiomics Toolbox for High-Throughput Single-Cell Analysis. Molecular Biology and Evolution. 40(12). 2 indexed citations
10.
Pan, Lu, et al.. (2023). Characterization of the m6A regulator-mediated methylation modification patterns in oral squamous cell carcinoma. Scientific Reports. 13(1). 6617–6617. 4 indexed citations
11.
Zhu, Zhixin, Lulu Jin, Yong Gao, et al.. (2023). C-176 loaded Ce DNase nanoparticles synergistically inhibit the cGAS-STING pathway for ischemic stroke treatment. Bioactive Materials. 29. 230–240. 36 indexed citations
12.
Seitz, Christina, Can Cui, Anikó Lovik, et al.. (2022). T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression. Nature Communications. 13(1). 6733–6733. 51 indexed citations
13.
Pan, Lu, Jiahao Yang, & Lan Xu. (2022). Preparation and Characterization of Simvastatin-Loaded PCL/PEG Nanofiber Membranes for Drug Sustained Release. Molecules. 27(21). 7158–7158. 22 indexed citations
14.
Pan, Lu, et al.. (2021). RAMP-TAO. Proceedings of the VLDB Endowment. 14(12). 3014–3027. 9 indexed citations
15.
Wang, Qiong, Yuchao Zhang, Lifang Zhu, et al.. (2019). Heat shock factor 1 in cancer‐associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma. Cancer Science. 110(5). 1790–1803. 15 indexed citations
16.
Leong, Jing Yao, Joo Guan Yeo, Camillus Chua, et al.. (2019). Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal. Annals of the Rheumatic Diseases. 78(12). 1712–1721. 17 indexed citations
17.
Li, Bang, Jia‐Yi Zhang, Lifang Zhu, et al.. (2019). TLR2 deficiency enhances susceptibility to oral carcinogenesis by promoting an inflammatory environment.. PubMed. 9(12). 2599–2617. 5 indexed citations
18.
Chew, Valerie, Yun Hua Lee, Lu Pan, et al.. (2018). Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma. Gut. 68(2). 335–346. 164 indexed citations
19.
Lim, Chun Jye, Yun Hua Lee, Lu Pan, et al.. (2018). Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma. Gut. 68(5). 916–927. 259 indexed citations
20.
Pan, Lu, et al.. (2017). Control system design and kinematic analysis for a 4-DOF light weight manipulator. 2010. 5673–5678. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026